KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 295 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,216 | +129.9% | 7,000 | +22.8% | 0.01% | +120.0% |
| Q3 2023 | $964 | -12.8% | 5,700 | +11.8% | 0.01% | -16.7% |
| Q2 2023 | $1,106 | +60.3% | 5,100 | +34.2% | 0.01% | +50.0% |
| Q1 2023 | $690 | -7.6% | 3,800 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $747 | -99.9% | 3,800 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $855,000 | +98.8% | 3,800 | +11.8% | 0.01% | +100.0% |
| Q2 2022 | $430,000 | -0.2% | 3,400 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $431,000 | -37.9% | 3,400 | -35.8% | 0.00% | -33.3% |
| Q4 2021 | $694,000 | +1.3% | 5,300 | -5.4% | 0.00% | -25.0% |
| Q3 2021 | $685,000 | +39.8% | 5,600 | +30.2% | 0.00% | +33.3% |
| Q2 2021 | $490,000 | +10.1% | 4,300 | +16.2% | 0.00% | 0.0% |
| Q1 2021 | $445,000 | +18.4% | 3,700 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $376,000 | -23.3% | 3,700 | -15.9% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |